Preclinical Assessment of Therapeutic Antibodies against Human CD40 and Human Interleukin-12/23p40 in a Nonhuman Primate Model of Multiple Sclerosis

Publisher： Karger

E-ISSN： 1660-2862|5|1|38-52

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.5, Iss.1, 2007-12, pp. : 38-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential Regulation of CD40-Mediated Human B Cell Responses by Antibodies Directed against Different CD40 Epitopes

By Sakata N.   Hamelmann E.   Siadak A.W.   Terada N.   Gerwins P.   Aruffo A.   Johnson G.L.   Gelfand E.W.  

Cellular Immunology, Vol. 201, Iss. 2, 2000-05 ,pp. : 109-123

Academic Press

Access to resources Recommend Favorite

Therapeutic Antibodies in Multiple Sclerosis

By  

Neurodegenerative Diseases, Vol. 5, Iss. 1, 2007-12 ,pp. : 5-7

Karger

Access to resources Recommend Favorite

FOLLOWING DIRECT CD40 ACTIVATION, HUMAN PRIMARY MICROGLIAL CELLS PRODUCE IL-12 p40 BUT NOT BIOACTIVE IL-12 p70

By de Goër de Herve M.G.   delfraissy J.F.   Taoufik Y.  

Cytokine, Vol. 14, Iss. 2, 2001-04 ,pp. : 88-96

Academic Press

Access to resources Recommend Favorite

The Role of CD40-CD40 Ligand Interactions in Suppression of Human B Cell Responsiveness by CD4+ T Cells

By Hirohata S.  

Cellular Immunology, Vol. 182, Iss. 1, 1997-11 ,pp. : 20-28

Academic Press

Access to resources Recommend Favorite

CD48 Delivers an Accessory Signal for CD40-Mediated Activation of Human B Cells

By Klyushnenkova E.N.   Li L.   Armitage R.J.   Choi Y.S.  

Cellular Immunology, Vol. 174, Iss. 1, 1996-11 ,pp. : 90-98

Academic Press

Access to resources Recommend Favorite